HALEO presents real-world data from its virtual care
June 10, 2022
| Reading time: 🕐 2m
For Immediate Release –
Montreal, QC, June 10th, 2022 - HALEO, a leading center of expertise in behavioural sleep health today announced interim real-world data from its virtual care CBTi protocol for Shiftwork delivered via videoconference (SW-CBTi), a program developed specifically for individuals with a complex rotating or nightshift schedule experiencing chronic insomnia. Patients achieved significant reductions in symptoms of insomnia, anxiety and depression following the intervention. These results were presented as a poster at the 36th Annual Meeting of the Associated Professional Sleep Societies (APSS), known as “SLEEP 2022” held June 4-8 in Charlotte, North Carolina.
“Shiftworkers are dealing with greater complexity when it comes to their sleep and are more likely to suffer from insomnia. They often work in safety-sensitive roles, and their insomnia puts them at higher risk of workplace accidents. For employers, poor sleep also increases other risks such as employee turnover, as well as higher rates of absenteeism, disability, and mental health disorders”, said Brad Smith, CEO of HALEO.
“The high demand from shiftworkers for our regular CBTi program led us to develop a specific protocol tailored to their needs. The primary objective of the protocol was to deliver a clinically significant reduction of symptoms of insomnia, depression, and anxiety. Our real-world data demonstrates that our shiftwork intervention is as effective as our market-leading CBT-I protocol, and that delivering it through our telehealth platform reduces the insomnia, depression and anxiety symptoms of shiftworkers in a highly significant manner” said Philippe Stenstrom, PhD, Scientific Director of HALEO.
Specifically, interim data showed participants treated with the HALEO SW-CBT-I program for shiftworkers experienced the following improvements:
ISI scores were significantly lower post-therapy (mean of = 7.23, SD = 4.11) compared to baseline (mean of = 16.90 SD = 3.69; significance of p<.001, Cohen’s d = 2.29).
HADS-Depression scores, which measure depressive symptoms were found to be significantly lower post-therapy (mean of = 2.83, SD = 3.08) compared to baseline (mean of = 5.12, SD = 3.68) significance of Cohen’s p<.001, d = 1.03).
HADS-Anxiety scores, which measure anxiety symptoms, were also significantly lower post-therapy (mean of = 5.08, SD = 2.97) compared to baseline (mean = 6.92, SD = 3.73; p<.001, Cohen’s d = 0.83).
HALEO’s SW-CBTi program is being rolled out to thousands of first responders, manufacturers, health care workers and other shiftworkers as part of its corporate health & safety solution, which is being adopted by leading employers throughout North America.
Founded in 2015, HALEO is an virtual care sleep clinic whose mission is to provide access to quality care based on clinically proven solutions for those suffering from insomnia or other sleep disorders. Its clinical experts provide personalized professional treatments supported by clinical research and accessible via a mobile application. The services offered, ranging from sleep screening to the management of sleep disorders, help improve the health and performance of thousands of people across North America by helping them overcome their sleep problems.